دوره 9، شماره 2 - ( 11-1403 )
جلد 9 شماره 2 صفحات 29-24 |
برگشت به فهرست نسخه ها
چکیده: (627 مشاهده)
Background: According to medical resources, iron deficiency anemia occurs after the depletion of iron stores when ferritin levels reach 15 micrograms per liter (μg/L) or less. However, clinical experiences show different results. This study aimed to determine the effectiveness of oral iron supplementation on hemoglobin levels in non-anemic women with serum ferritin levels of 15–50 μg/L.
Methods: Women aged 18 to 60 years with complaints of fatigue and/or anemia, hemoglobin above 12 grams per deciliter (g/dL) or above 11 g/dL with thalassemia minor characteristics, and ferritin levels of 15 to 50 μg/L were included. Participants were not pregnant and had no underlying acute or chronic disease. Those who did not take iron supplements regularly or did not attend a second appointment were excluded. Patients were treated with a daily oral ferrous sulfate iron supplement containing 50–100 milligrams (mg) of elemental iron for at least six weeks. Laboratory data were compared before and after treatment
Results: Fifty-two females with a mean age of 40.23 ± 16.31 years were included. The mean hemoglobin level before treatment was 12.40 ± 1.08 g/dL, increasing to 13.04 ± 1.04 g/dL after treatment (P < 0.001). The mean serum ferritin level increased from 27.51 μg/L before treatment to 51.81 μg/L after treatment (P < 0.001). Hemoglobin increments were also observed in two subgroups: those with ferritin levels of 15–30 μg/L (P < 0.001) and those with levels of 30–50 μg/L (P = 0.001).
Conclusion: Oral iron supplementation increases hemoglobin levels in non-anemic women with serum ferritin levels of 15–50 μg/L. It is advisable to consider ferritin levels below 50 μg/L as an indicator of depletion of iron body stores.
Methods: Women aged 18 to 60 years with complaints of fatigue and/or anemia, hemoglobin above 12 grams per deciliter (g/dL) or above 11 g/dL with thalassemia minor characteristics, and ferritin levels of 15 to 50 μg/L were included. Participants were not pregnant and had no underlying acute or chronic disease. Those who did not take iron supplements regularly or did not attend a second appointment were excluded. Patients were treated with a daily oral ferrous sulfate iron supplement containing 50–100 milligrams (mg) of elemental iron for at least six weeks. Laboratory data were compared before and after treatment
Results: Fifty-two females with a mean age of 40.23 ± 16.31 years were included. The mean hemoglobin level before treatment was 12.40 ± 1.08 g/dL, increasing to 13.04 ± 1.04 g/dL after treatment (P < 0.001). The mean serum ferritin level increased from 27.51 μg/L before treatment to 51.81 μg/L after treatment (P < 0.001). Hemoglobin increments were also observed in two subgroups: those with ferritin levels of 15–30 μg/L (P < 0.001) and those with levels of 30–50 μg/L (P = 0.001).
Conclusion: Oral iron supplementation increases hemoglobin levels in non-anemic women with serum ferritin levels of 15–50 μg/L. It is advisable to consider ferritin levels below 50 μg/L as an indicator of depletion of iron body stores.
شمارهی مقاله: 4
نوع مطالعه: پژوهشی اصیل |
موضوع مقاله:
هماتولوژی
دریافت: 1404/6/31 | پذیرش: 1405/3/16 | انتشار: 1405/3/16
دریافت: 1404/6/31 | پذیرش: 1405/3/16 | انتشار: 1405/3/16
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |